Search Results

There are 12699 results for: content related to: Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study

  1. You have free access to this content
    Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis – a pooled analysis

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 9, November 2011, Pages: 1115–1122, L. Leifeld, R. Pfützer, J. Morgenstern, P. R. Gibson, Y. Marakhouski, R. Greinwald, R. Mueller and W. Kruis

    Version of Record online : 19 SEP 2011, DOI: 10.1111/j.1365-2036.2011.04840.x

  2. You have free access to this content
    The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 11-12, December 2008, Pages: 1287–1296, A. BUCKLAND and K. BODGER

    Version of Record online : 19 SEP 2008, DOI: 10.1111/j.1365-2036.2008.03856.x

  3. You have free access to this content
    Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 9, September 2000, Pages: 1191–1198, Pokrotnieks, Marlicz, Paradowski, Margus, Zaborowski and Greinwald

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00784.x

  4. You have free access to this content
    Systematic review: the use of mesalazine in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 7, April 2006, Pages: 841–855, R. BERGMAN and M. PARKES

    Version of Record online : 17 MAR 2006, DOI: 10.1111/j.1365-2036.2006.02846.x

  5. Pharmacokinetics of mesalazine pellets in children with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 5, September 2004, Pages: 626–631, Heleen Wiersma, Johanna C. Escher, Karin Dilger, Dietmar Trenk, Marc A. Benninga, Chris J. van Boxtel and Jan Taminiau

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200409000-00019

  6. Is Once-Daily Mesalazine Equivalent to the Currently Used Twice-Daily Regimen? A Study Performed in 30 Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 3, March 2007, Pages: 334–342, Dr Peggy Gandia, Dr Isabelle Idier and Dr Georges Houin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006296522

  7. You have free access to this content
    Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 12, June 2007, Pages: 1389–1399, A. H. STEINHART, A. FORBES, E. C. MILLS, B. S. RODGERS-GRAY and S. P. L. TRAVIS

    Version of Record online : 30 MAR 2007, DOI: 10.1111/j.1365-2036.2007.03324.x

  8. You have free access to this content
    Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 11, November 1999, Pages: 1413–1417, Frieri, Pimpo, Palumbo, Onori, Viscido, Latella, Galletti, Pantaleoni and Caprilli

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00642.x

  9. You have free access to this content
    Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 8, April 2013, Pages: 767–775, B. Flourié, H. Hagège, G. Tucat, D. Maetz, X. Hébuterne, J. P. Kuyvenhoven, T. G. Tan, M. J. Pierik, A. A. M. Masclee, O. Dewit, C. S. Probert, D. Aoucheta and the MOTUS study investigators

    Version of Record online : 4 MAR 2013, DOI: 10.1111/apt.12266

  10. You have free access to this content
    MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 11, June 2008, Pages: 1094–1102, G. R. LICHTENSTEIN, M. A. KAMM, W. J. SANDBORN, A. LYNE and R. E. JOSEPH

    Version of Record online : 22 MAR 2008, DOI: 10.1111/j.1365-2036.2008.03688.x

  11. You have free access to this content
    Short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 19, Issue 2, January 2004, Pages: 179–189, E. V. Loftus JR, S. V. Kane and D. Bjorkman

    Version of Record online : 14 JAN 2004, DOI: 10.1111/j.0269-2813.2004.01827.x

  12. You have free access to this content
    Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 9, November 2007, Pages: 1179–1186, A. V. SAFDI and R. D. COHEN

    Version of Record online : 20 AUG 2007, DOI: 10.1111/j.1365-2036.2007.03471.x

  13. You have free access to this content
    Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 12, Issue 8, August 1998, Pages: 707–715, Kruis, Brandes, Schreiber, Theuer, Krakamp, Schütz, Otto, Lorenz-Mayer, Ewe and Judmaier

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2036.1998.00360.x

  14. You have free access to this content
    Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 7, April 2006, Pages: 1017–1026, P. R. GIBSON, B. FIXA, B. PEKÁRKOVÁ, M. BÁTOVSKÝ, G. RADFORD-SMITH, J. TIBITANZL, L. GABALEC, T. H. J. FLORIN and R. GREINWALD

    Version of Record online : 17 MAR 2006, DOI: 10.1111/j.1365-2036.2006.02861.x

  15. You have full text access to this OnlineOpen article
    Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 5, September 2013, Pages: 531–538, A. Robinson, M. Hankins, G. Wiseman and M. Jones

    Version of Record online : 8 JUL 2013, DOI: 10.1111/apt.12396

  16. You have free access to this content
    Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 6, September 2015, Pages: 664–684, A. Tursi, A. Papa and S. Danese

    Version of Record online : 22 JUL 2015, DOI: 10.1111/apt.13322

  17. You have free access to this content
    A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 3, March 1999, Pages: 381–388, GIONCHETTI, ARDIZZONE, BENVENUTI, BIANCHI PORRO, BIASCO, CESARI, D'ALBASIO, DE FRANCHIS, MONTELEONE, PALLONE, RANZI, TRALLORI, VALPIANI, VECCHI and CAMPIERI

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00482.x

  18. You have free access to this content
    Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation – a placebo-controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 3, August 2013, Pages: 264–273, M. Watanabe, H. Nishino, Y. Sameshima, A. Ota, S. Nakamura and T. Hibi

    Version of Record online : 5 JUN 2013, DOI: 10.1111/apt.12362

  19. Mesalazine in childhood inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 3, Issue 6, December 1989, Pages: 597–604, L. BARDEN, A. LIPSON, P. PERT and J. A. WALKER-SMITH

    Version of Record online : 31 MAR 2007, DOI: 10.1111/j.1365-2036.1989.tb00253.x

  20. You have free access to this content
    Gastrointestinal spread of oral prolonged-release mesalazine microgranules (Pentasa) dosed as either tablets or sachet

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 2, February 2000, Pages: 163–169, Wilding, Kenyon and Hooper

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00696.x